Page results
-
The haematology and critical care services in our flagship University College Hospital Grafton Way Building are now open.
-
This Mobile Health Clinic has been extensively refurbished and fitted with a new digital portable x-ray camera and modern technologies to speed patient diagnoses and treatment of infectious diseases that will be powered on green energy.
-
This page explains the use of Xeomin® botulinum toxin for the treatment of uncontrolled saliva (known as sialorrhea).
-
Mixed sex accommodation and privacy information for patients coming into hospital for an inpatient stay
-
Our vaccination centre at the Business Design Centre, Islington, closed on Monday 10 January.
-
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at University College London Hospitals (UCLH) NHS Foundation Trust.
-
Having proton beam therapy: information for teenagers aged 13-17 patient information.
-
Having proton beam therapy: information for children aged 9-12 patient information
-
Having proton beam therapy: information for children aged 5-8 patient information page.
-
University College London Hospitals (UCLH) is now administering new COVID-19 treatments for patients at highest risk in the community.
File results
-
FOI/2024/0607 - Starvation ketoacidosis patients/ treatment
-
FOI/2024/0609 - Healthcare Associated Infections (HAIs) cases
-
FOI/2024/0615 - Electronic Patient Record (EPR) software spend/ Trust Integration Engine (TIE)
-
FOI/2024/0612 - Orthotic and prosthetic services at the Trust
-
FOI/2024/0616 - Never events involving Medical Associate Professionals (MAPs) from 2021/22-2023/24
-
FOI/2024/0617 - Vascular access devices purchased - Peripherally Inserted Central Catheters (PICC)/ Midline Catheters
-
FOI/2024/0622 - Guidelines and policies for the treatment of Dravet and Lennox-Gastaut syndrome
-
FOI/2024/0623 - Patient numbers sent to use MRI scanner at London Zoo from 2014-2024
-
FOI/2024/0626 - Number of patients with Waldenström Macroglobulinemia and treatments
-
FOI/2024/0627 - E-signature vendor supplier and cost